Adtran Holdings Inc

This proposal asks shareholders to approve an amendment to the Company’s Amended and Restated Certificate of Incorporation to extend exculpation (monetary liability limitation) to certain officers to the fullest extent permitted under amended Delaware law (DGCL Section 102(b)(7)) and to simplify Section 7.1 so director and officer exculpation tracks whatever the DGCL permits in the future. Management seeks shareholder approval to align the charter with the DGCL change that now allows limited exculpation for specific officer roles and named executive officers identified in SEC filings, while expressly preserving liability for duty-of-loyalty breaches, bad faith, intentional misconduct, knowing law violations, and improper personal benefit. The Board frames the change as narrow (limited to direct stockholder claims for breach of the duty of care) and necessary to attract and retain qualified officers who might otherwise be deterred by personal exposure and the risk of costly, meritless litigation. The amendment also replaces prescriptive statutory text with a flexible, “to the fullest extent permitted by law” clause intended to reduce the need for future charter amendments if Delaware law evolves further. The company notes that many Delaware corporations have adopted similar provisions since the statutory amendment, signaling market practice and comparability considerations. While exculpation reduces certain enforcement tools available to shareholders in direct duty-of-care suits, the proposal preserves core fiduciary protections (duty of loyalty, bad faith, intentional misconduct, and unlawful acts) and does not affect derivative claims by the company. The Board’s recommendation emphasizes governance and recruiting benefits and the limited scope of relief sought. In evaluating this, an analyst should weigh the governance trade-off between insulating officers from hindsight-based monetary exposure and the potential impact on managerial accountability and shareholder remedies, as well as consider the company’s governance quality, board oversight, and historical litigation risk when deciding whether the net effect favors shareholder interests.

This advisory proposal requests a non-binding shareholder vote to approve the compensation paid to the company’s named executive officers as disclosed in the proxy, including the Compensation Discussion & Analysis and executive pay tables. Management frames the program as performance‑oriented (mix of cash incentives tied to Adjusted EBIT and revenue, market‑based PSUs tied to relative TSR, and performance PSUs linked to multi-year Adjusted EBIT targets), designed to retain executives and align management with stockholder interests. The Compensation Committee notes prior strong shareholder support (94.7% in 2025) and intends to continue emphasizing performance-based awards and pay-for-performance alignment. While the vote is advisory and not legally binding, the Board and Compensation Committee state they will consider the outcome when setting future pay policies and may respond to a material negative vote by adjusting program design or engagement. From a governance perspective, the key considerations are whether disclosed targets, payout caps, and discretion mechanisms create appropriate incentives without encouraging undue risk, whether performance metrics match strategic priorities, and whether realized pay tracks company performance and TSR over relevant horizons. Analysts should evaluate the composition of pay (short-term vs long-term, time-based vs performance-based equity), the rigor of targets, any special retention or change-in-control protections, and recent outcomes (e.g., 200% payout under 2025 VICC) to assess whether pay is reasonably linked to sustained shareholder value creation. Given the Board’s commitment to consider investor feedback, a substantial negative advisory vote would likely trigger direct engagement and possible program changes.